WebDec 10, 2015 · In contrast to conventional cancer therapeutics, novel approaches such as ligand or receptor based targeting, triggered release, intracellular drug targeting, gene … WebDec 10, 2024 · Such novel drug delivery approaches, based on the clear understanding of the intrinsic properties of GBM, have shown promise in overcoming some of the obstacles. In this review, we first recapitulate the first-line therapy and clinical challenges in the current treatment of GBM.
(PDF) CNS Drug Delivery Systems: Novel Approaches
WebFeb 1, 2024 · Overcoming antibacterial resistance by novel drug delivery approach offered new hopes, particularly in the treatment of AMR pathogens in sites less assessible through systemic circulation such as the lung and skin. In the current review, we will revisit the mechanism and incidence of important AMR pathogens. Finally, we will discuss novel … WebFeb 28, 2024 · Novel approaches to extended-release drug delivery. A number of novel NP formulations for extended drug release have been developed in recent years. For instance, PLGA polymers have been shown to attain 82% of … philip ac1215
Overcoming the rising incidence and evolving mechanisms
WebFeb 17, 2024 · Novel drug delivery system refers to approaches formulation technology and system for transporting a pharmaceutical compound in the body as a needed to safety achieve desired therapeutic... WebApr 11, 2024 · 9 Novel Technologies for Drug Delivery Approach [ 111] Novel drug delivery systems (NDDS) will be a boon for the better and target-specific delivery of repurposed drugs. Currently ongoing research exemplify the execution of NDDS in prevention and treatment of COVID-19 as well as in the vaccine development process. WebOct 24, 2024 · Applications of nanotechnology and material sciences emerge in the development of various novel drug delivery systems that have been proven as promising clinically. Among these, liposomes, noisome, polymeric carriers and lipid-based delivery system were extensively explored and enter into clinical trials and clinical applications. philip account